John W. Rogers Jr. Holdings Activity

Ariel Appreciation Fund Portfolio 13F

Ariel Appreciation Fund has disclosed a total of 29 changes to the portfolio in the latest (2023 Q4) SEC report(s): increased the number of shares of 9 and decreased the number of shares of 20 position(s).

What stocks is John W. Rogers Jr. buying now?

In the recent quarter John W. Rogers Jr. has bought 9 securities out of which top 5 purchases (by % change to portfolio) are (NVST) ENVISTA HOLDINGS CORP (added shares +34.23%), (KEYS) KEYSIGHT TECHNOLOGIES IN (added shares +28.57%), (CG) CARLYLE GROUP INC/THE (added shares +14.66%), (IPG) INTERPUBLIC GROUP OF COS INC (added shares +11.6%) and (KN) KNOWLES CORP (added shares +14%).

What does John W. Rogers Jr. invest in?

John W. Rogers Jr.'s top 5 holdings (by % of portfolio) are (NTRS) NORTHERN TRUST CORP (4.18%), (GS) GOLDMAN SACHS GROUP INC (3.94%), (SCHW) SCHWAB (CHARLES) CORP (3.64%), (CRL) CHARLES RIVER LABORATORIES (3.38%) and (LH) LABORATORY CRP OF AMER HLDGS (3.25%).

In the latest report(s) the following changes have been made to the top investments: (NTRS) NORTHERN TRUST CORP (reduced shares -0.34%), (GS) GOLDMAN SACHS GROUP INC (reduced shares -10.03%), (SCHW) SCHWAB (CHARLES) CORP (reduced shares -2.88%), (CRL) CHARLES RIVER LABORATORIES (reduced shares -9.19%) and (LH) LABORATORY CRP OF AMER HLDGS (reduced shares -10.75%).

2023 Q2 (45 results)
MAT
+9.33%
+188,071
+0.33%
$19.54
7.47% $18.08
3.88%
LH
buy
+171,098
+3.72%
$241.33
16.58% $201.32
3.72%
NTRS
buy
+531,348
+3.55%
$74.14
12.02% $83.05
3.55%
GS
buy
+121,510
+3.53%
$322.54
32.37% $426.95
3.53%
KMX
-13.49%
-71,303
-0.54%
$83.70
19.70% $67.21
3.45%
SCHW
+4.52%
+27,130
+0.14%
$56.68
31.56% $74.57
3.20%
CRL
+13.11%
+19,533
+0.37%
$210.25
10.67% $232.69
3.19%
KMT
-6.63%
-85,461
-0.22%
$28.39
16.52% $23.70
3.08%
SWK
-5.90%
-22,792
-0.19%
$93.71
1.93% $91.90
3.07%
IPG
-12.18%
-121,313
-0.42%
$38.58
20.94% $30.50
3.04%
BWA
buy
+662,265
+2.92%
$48.91
32.79% $32.87
2.92%
CLB
buy
+1,390,927
+2.91%
$23.25
32.43% $15.71
2.91%
AXTA
-18.38%
-211,769
-0.63%
$32.81
4.27% $34.21
2.78%
GNRC
buy
+197,594
+2.66%
$149.13
14.42% $127.63
2.66%
NVT
-24.77%
-180,371
-0.84%
$51.67
37.55% $71.07
2.55%
NTPXX
buy
+28,112,369
+2.53%
$1.00
-
2.53%
KKR
buy
+484,025
+2.44%
$56.00
69.86% $95.12
2.44%
MANU
-22.86%
-316,364
-0.70%
$24.38
34.29% $16.02
2.35%
LAZ
buy
+808,934
+2.33%
$32.00
19.44% $38.22
2.33%
MSGS
buy
+136,315
+2.31%
$188.05
1.22% $185.76
2.31%
CBRE
-8.31%
-28,557
-0.21%
$80.71
6.89% $86.27
2.29%
AFL
-32.20%
-169,487
-1.07%
$69.80
21.16% $84.57
2.25%
KN
-12.06%
-180,487
-0.29%
$18.06
12.51% $15.80
2.14%
ZBH
buy
+161,096
+2.11%
$145.60
17.88% $119.56
2.11%
REZI
buy
+1,292,985
+2.06%
$17.66
9.23% $19.29
2.06%
LFUS
-16.20%
-15,034
-0.39%
$291.31
19.90% $233.35
2.04%
SRCL
-9.56%
-51,493
-0.22%
$46.44
4.61% $44.30
2.04%
BOKF
buy
+266,629
+1.94%
$80.78
11.71% $90.24
1.94%
WBA
+10.61%
+72,076
+0.19%
$28.49
39.14% $17.34
1.93%
FAF
buy
+364,366
+1.87%
$57.02
6.68% $53.21
1.87%
NVST
-2.34%
-14,289
-0.04%
$33.84
41.64% $19.75
1.82%
TAP
-10.20%
-33,855
-0.20%
$65.84
13.30% $57.08
1.77%
KEYS
-9.99%
-12,589
-0.19%
$167.45
13.44% $144.95
1.71%
MSGE
buy
+549,756
+1.67%
$33.62
17.67% $39.56
1.67%
CG
buy
+530,070
+1.53%
$31.95
28.23% $40.97
1.53%
NOV
+67.04%
+407,582
+0.59%
$16.04
14.59% $18.38
1.47%
JLL
+66.37%
+39,470
+0.55%
$155.80
15.80% $180.41
1.39%
MTN
-15.85%
-11,247
-0.26%
$251.76
24.07% $191.17
1.35%
VIAC
buy
+879,199
+1.26%
$15.91
85.92% $29.58
1.26%
SJM
-15.47%
-16,233
-0.22%
$147.67
23.07% $113.60
1.18%
ADT
+13.54%
+199,384
+0.11%
$6.03
7.79% $6.50
0.91%
SNA
buy
+35,183
+0.91%
$288.19
7.10% $267.74
0.91%
MSGE
buy
+318,217
+0.79%
$27.39
44.43% $39.56
0.79%
CAH
-100.00%
-152,395
-1.04%
$75.50
35.32% $102.17
0.00%
CLB
-100.00%
-1,301,527
-2.59%
$22.05
28.75% $15.71
0.00%
45 of 523

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.